Orchid Pharma Limited(IN:ORCHPHARMA)
₹881.50+24.00 (+2.80%)
IN:ORCHPHARMA
Orchid Pharma Limited financials statements
₹881.50
At close:+24.00 (+2.80%)
Want to see IN:ORCHPHARMA full AI Analyst Report?
Orchid Pharma Limited (ORCHPHARMA) Income Statement
0 Followers
Orchid Pharma Limited Income Statement
Last quarter (Q1 2027), Orchid Pharma Limited's total revenue was ₹3.04B, an increase of 75.89% from the same quarter last year. In Q1, Orchid Pharma Limited's net income was ₹32.24M. See Orchid Pharma Limited’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| ₹ 8.11B | ₹ 9.22B | ₹ 8.19B | ₹ 6.66B | ₹ 5.60B | |
| ₹ 1.59B | ₹ 3.55B | ₹ 1.36B | ₹ 706.89M | ₹ 2.32B | |
| ₹ 1.53B | ₹ 1.21B | ₹ 584.47M | ₹ 410.20M | ₹ 2.66B | |
| Depreciation and Amortization | ₹ 432.46M | ₹ 345.46M | ₹ 332.37M | ₹ 547.87M | ₹ 870.25M |
| ₹ 489.22M | ₹ 1.45B | ₹ 1.42B | ₹ 1.43B | ₹ 621.38M | |
| ₹ 56.76M | ₹ 811.13M | ₹ 777.04M | ₹ 296.69M | ₹ -338.90M | |
| ₹ 146.80M | ₹ 183.50M | ₹ 113.43M | ₹ 255.78M | ₹ -230.09M | |
| ₹ 203.55M | ₹ 994.63M | ₹ 890.47M | ₹ 552.47M | ₹ -568.99M | |
| ₹ 205.47M | ₹ 996.57M | ₹ 921.66M | ₹ 463.18M | ₹ -19.51M | |
| Per Share Metrics | |||||
| Basic EPS | ₹ 4.05 | ₹ 19.65 | ₹ 19.06 | ₹ 11.35 | ₹ -0.48 |
| Diluted EPS | ₹ 4.05 | ₹ 19.65 | ₹ 19.06 | ₹ 11.35 | ₹ -0.48 |
| Weighted Average Shares Outstanding | 50.73M | 50.72M | 48.37M | 40.82M | 40.82M |
| Weighted Average Shares Outstanding (Diluted) | 50.73M | 50.72M | 48.37M | 40.82M | 40.82M |
Currency in INR
